CT在经导管瓣膜性心脏病治疗中的应用
本文概述了术前影像学策略及后处理方法,重点讨论CT在经导管主动脉瓣、二尖瓣和三尖瓣治疗中的应用,并介绍了设备细节、CT成像目标及未来影像发展方向。
要点
- 术前影像策略因目标瓣膜不同而异,CT是核心模态之一。
- 经导管主动脉瓣置换术的CT评估需关注设备特异性细节。
- 未来方向包括围术期融合成像、机器学习图像处理和混合现实应用。
核心结论
- 本文综述了经导管瓣膜性心脏病治疗的术前影像策略及后处理方法,重点阐述CT在主动脉瓣、二尖瓣和三尖瓣介入治疗中的应用,并展望了融合成像、机器学习和混合现实等未来发展方向。
研究设计与样本
- 综述类文章,检索范围与纳入文献原文未报告;文章概述了术前影像策略及后处理方法,重点讨论CT,并涉及经导管主动脉瓣置换术及二尖瓣、三尖瓣的微创治疗。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Minimally invasive strategies to treat valvular heart disease have emerged over the past 2 decades. The use of transcatheter aortic valve replacement in the treatment of severe aortic stenosis, for example, has recently expanded from high- to low-risk patients and became an alternative treatment for those with prohibitive surgical risk. With the increase in transcatheter strategies, multimodality imaging, including echocardiography, CT, fluoroscopy, and cardiac MRI, are used. Strategies for preprocedural imaging strategies vary depending on the targeted valve. Herein, an overview of preprocedural imaging strategies and their postprocessing approaches is provided, with a focus on CT. Transcatheter aortic valve replacement is reviewed, as well as less established minimally invasive treatments of the mitral and tricuspid valves. In addition, device-specific details and the goals of CT imaging are discussed. Future imaging developments, such as peri-procedural fusion imaging, machine learning for image processing, and mixed reality applications, are presented.
引用
- Rudzinski PN, Leipsic JA, Schoepf UJ, et al. CT in Transcatheter-delivered Treatment of Valvular Heart Disease. Radiology. 2022. PMID: 35638923. doi:10.1148/radiol.210567
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。